RCUS - Arcus Biosciences, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Arcus Biosciences GAAP EPS of -$1.08 misses by $0.06, revenue of $31M beats by $2.7M
• Arcus Biosciences Q4 2023 Earnings Preview
• Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
• Arcus shares extend gains amid mixed reactions on Gilead stake purchase
• Gilead invests $320M in Arcus, expands stake to 33%
• Arcus posts early-stage data for Gilead-partnered cancer therapy
• Arcus, Bristol-Myers, and R1 RCM are Citi’s top stocks in healthcare
• Arcus Biosciences GAAP EPS of -$0.94 beats by $0.19, revenue of $32M beats by $4.44M
• Arcus Biosciences Q3 2023 Earnings Preview
• Roche sends anti-TIGIT developers higher after cancer drug data (update)
• ITOS, APLS and TIVC among top healthcare movers
• Arcus Biosciences GAAP EPS of -$1.04, revenue of $29M
• Acumen, BridgeBio, Arcus among BTIG's top healthcare picks for 2H 2023
• Gilead raises stake in Arcus Biosciences
• Roche drives rival anti-TIGIT developers higher after cancer drug data
• Gilead projects earnings impact after expanding research deal with Arcus
• Arcus Biosciences GAAP EPS of -$1.09 beats by $0.10, revenue of $25M beats by $2.53M
• Arcus Biosciences GAAP EPS of -$0.93 beats by $0.17, revenue of $34M beats by $10.28M
• Roche CEO drags Arcus, iTeos lower after comments on cancer trial
• Gilead and Arcus issue update from mid-stage trial for lung cancer therapy